Recalls / Brands / Heparin Sodium
Heparin Sodium
5 FDA drug recalls involving brand “Heparin Sodium” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-02-28 | Class II | Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous o | Sagent Pharmaceuticals Inc |
| 2022-12-29 | Class II | Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bag | Pfizer Inc. |
| 2014-09-11 | Class I | HEPARIN SODIUM, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 | Hospira Inc. |
| 2014-01-22 | Class II | Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose | Fresenius Kabi USA, LLC |
| 2014-01-09 | Class II | Heparin Sodium 2000 USP Heparin Units per 1000 mL (2 USP Heparin Units/mL) in 0.9% Sodium Chloride Injection, | Hospira Inc. |